Articles By Rob Wright, Chief Editor 2011-2021
-
![My 10 Favorite Quotes From George Yancopoulos]( "My 10 Favorite Quotes From George Yancopoulos")
My 10 Favorite Quotes From George Yancopoulos4/24/2018My 10 favorite quotes from interviewing George Yancopoulos, M.D., Ph.D., president and chief scientific officer at Regeneron Pharmaceuticals.
-
![RobWright]( "Breakthroughs, Patients, Pricing, And Profits")
Breakthroughs, Patients, Pricing, And Profits4/6/2018How is our industry doing regarding innovation? A closer look at the number of Breakthrough Therapy Designations (BTDs) may give us an indication of our progress.
-
![John_Maraganore_Bucket]( "Alnylam – Poised To Deliver Its Breakthrough In 2018")
Alnylam – Poised To Deliver Its Breakthrough In 20184/6/2018In 2018, Alnylam seems poised to deliver its first big breakthrough. John Maraganore, CEO, sat down with LSL Chief Editor, Rob Wright, to share his perspectives on Alnylam’s upcoming year — including the good, the bad, and everything in-between.
-
![How Can The Pharma Industry Help The Homeless?]( "How Can The Pharma Industry Help The Homeless?")
How Can The Pharma Industry Help The Homeless?3/23/2018Readers provide feedback and suggestions around how the biopharmaceutical industry could help the homeless during the annual J.P. Morgan Healthcare Conference in San Francisco.
-
![The R&D Leadership Summit 2018 — One Hot Ticket]( "The R&D Leadership Summit 2018 — One Hot Ticket")
The R&D Leadership Summit 2018 — One Hot Ticket3/9/2018The Conference Forum’s 2018 R&D Leadership Summit employs the Chatham House Rule, which limits what information can be revealed from the event's proceedings. As one of the only members of the media in the room, Chief Editor Rob Wright shares what he can from this year's event, which had the theme “Growth: Where Will It Come From?”
-
![Feature Seattle Genetics_Clay Siegall_Herald_450x300]( "What's Next For Seattle Genetics?")
What's Next For Seattle Genetics?3/7/2018Clay Siegall, Ph.D., president, CEO, and chairman of Seattle Genetics, gives an exclusive interview about his company’s potential blockbuster, how they got to this point, and what’s next.
-
![RobWright]( "Do You Believe Print Publications Are Dead?")
Do You Believe Print Publications Are Dead?3/7/2018Print is not dead. In fact, Chief Editor Rob Wright believes we are on the verge of print’s resurgence, perhaps something similar to what’s being witnessed in the music industry with vinyl.
-
![J&J’s Addition Of JLABS in New York City Creates Buzz At BIO CEO 2018]( "J&J's Addition Of JLABS in New York City Creates Buzz At BIO CEO 2018")
J&J's Addition Of JLABS in New York City Creates Buzz At BIO CEO 20182/16/2018Rob Wright interviews Kate Merton, head of Johnson & Johnson Innovation’s newly created JLABS in New York City.
-
![Jeremy Levin On BIO’s Efforts Toward Tackling The Opioid Crisis]( "Jeremy Levin On BIO's Efforts Toward Tackling The Opioid Crisis")
Jeremy Levin On BIO's Efforts Toward Tackling The Opioid Crisis2/16/2018Rob Wright interviews Jeremy Levin, chairman and CEO of Ovid Therapeutics, about the BIO opioid crisis working group he is chairing.
Rob Wright
Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL